Opioid Maker Insys Pleads Guilty, Pays $225M In Fines, False Claims Settlement
BOSTON — A subsidiary of opioid manufacturer Insys Therapeutics Inc. on June 5 pleaded guilty to mail fraud and the parent company agreed to pay $225 million in fines, forfeiture and...To view the full article, register now.
Already a subscriber? Click here to view full article